Co-Prescribed Medications Prove Injury Severity: What Attorneys Miss in Pharmacy Records

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 4, 2026 | 8 min read

When multiple medications are prescribed together, the combination tells a clinical story that individual drugs do not. Learn how co-prescribing patterns in pharmacy records reveal injury severity, multi-system damage, and treatment complexity that plaintiff attorneys can leverage for higher case value.

Co-prescribing patterns -- the specific combinations of medications a plaintiff receives simultaneously -- reveal injury severity and clinical complexity that individual medication names alone do not convey. A plaintiff on gabapentin, cyclobenzaprine, omeprazole, and sertraline is not just taking four medications. They are being treated for neuropathic pain, muscle spasm, medication-induced GI damage, and accident-related depression -- four distinct clinical problems arising from a single injury event. Attorneys who understand co-prescribing patterns can present a far more compelling damages narrative than those who simply list medications.

• Co-prescribing patterns reveal multi-system injury impact -- each additional medication class represents a separate clinical problem the plaintiff is managing
• Protective co-prescriptions (like omeprazole with NSAIDs) document that the primary treatment carries enough risk that the prescriber added a medication solely to manage side effects
• The number of concurrent medication classes correlates with clinical complexity and is a recognized metric of disease burden in medical literature
• LienScripts analyzes co-prescribing patterns in every MERIT (Medication Evaluation & Rationale for Injury Treatment) report, explaining the clinical significance of each combination
• Defense counsel who focuses on individual medications misses the composite picture that co-prescribing reveals about overall injury severity

Why Co-Prescribing Matters

A prescriber who writes one prescription is treating one problem. A prescriber who writes five concurrent prescriptions is managing a complex clinical situation with multiple interacting conditions. The co-prescribing pattern is itself evidence of severity -- it documents that the injury created enough clinical problems to require management across multiple pharmacological fronts.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "When I review a plaintiff's medication regimen and see four or five concurrent prescriptions covering different body systems, that tells me this is not a minor injury. The prescriber is managing pain, managing nerve damage, managing muscle dysfunction, managing the GI effects of the pain medications, and managing the psychological toll. Each layer of co-prescribing is evidence that the injury's reach extends further than the defense wants to acknowledge."

Categories of Co-Prescribing Patterns

Multi-Mechanism Pain Management

The most common co-prescribing pattern in PI cases is multi-mechanism pain management, where the prescriber addresses different types of pain simultaneously:

• NSAID (meloxicam, celecoxib) for inflammatory pain
• Neuropathic agent (gabapentin, pregabalin) for nerve pain
• Muscle relaxant (cyclobenzaprine, tizanidine) for spasm
• Opioid analgesic (hydrocodone, oxycodone) for severe breakthrough pain

When all four classes are prescribed concurrently, it documents a complex pain syndrome involving inflammation, nerve damage, and muscle dysfunction -- three distinct pathological processes requiring three or four distinct pharmacological approaches. This is not a single ache managed with a single pill. It is a multi-system injury requiring multi-mechanism treatment.

Protective Co-Prescriptions

Protective co-prescriptions are medications added solely to prevent harm from other medications in the regimen. These are particularly powerful evidence because they document that the primary treatment carries significant risk:

• Proton pump inhibitor (omeprazole, pantoprazole) with NSAIDs -- the prescriber added GI protection because the anti-inflammatory medication risks stomach ulceration
• Stool softener (docusate) with opioids -- opioid-induced constipation is severe enough to require prophylactic treatment
• Anti-nausea medication (ondansetron) with opioids -- the pain medication causes nausea that itself requires pharmacological management
• Gastroprotective agent with steroids -- corticosteroids risk GI erosion, requiring co-prescribed protection

Each protective co-prescription tells the adjuster or jury: "This plaintiff's injury is severe enough to require a medication that itself causes problems requiring additional medication to manage."

Psychological Co-Prescriptions

When the medication regimen includes both physical and psychological medications prescribed after the accident date, the co-prescribing pattern documents the injury's psychological impact:

• SSRI or SNRI (sertraline, duloxetine) for depression or anxiety co-prescribed with pain medications
• Sleep medication (trazodone, hydroxyzine) co-prescribed with pain medications, indicating pain is disrupting sleep
• Anti-anxiety medication (buspirone, hydroxyzine) co-prescribed with pain medications, indicating the injury has generated anxiety

The co-prescribing of psychiatric medications alongside pain medications documents that the injury affected not just the plaintiff's body but their mental health -- a distinct category of damages.

Adjunctive and Rehabilitative Co-Prescriptions

• Topical analgesics (lidocaine patches, diclofenac gel) co-prescribed with oral medications indicate that oral medications alone are insufficient
• Vitamin D, calcium, or bone health medications co-prescribed after fracture injuries document ongoing skeletal rehabilitation
• Physical therapy-related medications (additional muscle relaxants or anti-inflammatories around PT sessions) indicate that rehabilitation itself causes additional pain requiring pharmacological management

Quantifying Complexity: The Medication Count Metric

The total number of concurrent prescription medications is a recognized metric of disease burden in medical literature. Studies consistently show that higher medication counts correlate with greater clinical complexity, higher healthcare utilization, and worse patient-reported outcomes.

For litigation purposes, the medication count frames the plaintiff's condition in accessible terms:

• 1-2 concurrent medications -- straightforward, single-system injury
• 3-4 concurrent medications -- moderate complexity, multi-system involvement
• 5-7 concurrent medications -- high complexity, significant multi-system injury
• 8+ concurrent medications -- catastrophic or polytrauma-level complexity

Presenting the medication count alongside the clinical explanation of why each medication is necessary transforms a pharmacy printout into a severity metric.

Using Co-Prescribing Data in Demand Packages

In a demand package, present co-prescribing patterns as a system-by-system injury analysis:

Physical Pain Management:

• Meloxicam 15mg daily -- inflammatory pain
• Gabapentin 600mg TID -- neuropathic pain
• Cyclobenzaprine 10mg TID -- muscle spasm

GI Protection (medication-induced):

• Omeprazole 20mg daily -- protecting against NSAID-induced GI damage

Psychological Impact:

• Sertraline 100mg daily -- accident-related depression
• Trazodone 50mg at bedtime -- pain-related sleep disruption

Total: Six concurrent medications across four body systems, all initiated after the accident date.

This format communicates severity far more effectively than a flat medication list. It shows the adjuster that the injury affected multiple body systems and required pharmacological management at every level.

Countering Defense Arguments

"The plaintiff is over-medicated."

Each medication in the regimen was prescribed by a licensed clinician for a specific clinical indication. The co-prescribing pattern reflects the complexity of the injury, not overtreatment. A MERIT report from LienScripts provides pharmacist-authored validation that each medication serves a necessary clinical purpose.

"Many of these medications are for pre-existing conditions."

The pharmacy fill history documents when each medication was first filled. Medications initiated after the accident date are temporally linked to the injury. Pre-accident medications that required dose increases after the accident document aggravation of pre-existing conditions.

"The plaintiff only has a soft tissue injury -- this medication regimen is excessive."

The co-prescribing pattern itself contradicts the characterization. A prescriber does not prescribe six concurrent medications for a minor soft tissue injury. The regimen complexity is evidence that the clinical picture is more severe than the defense characterization suggests.

The Clinical Pearl

Co-prescribing patterns are the composite picture that individual medications cannot provide. Every medication in the regimen tells a piece of the injury story, but the combination tells the whole story -- multi-system damage, treatment complexity, medication side effects requiring their own treatment, and psychological impact layered on top of physical injury. Attorneys who present this composite picture rather than a flat medication list will consistently communicate greater injury severity.

LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages that includes comprehensive co-prescribing analysis linking each medication to the clinical problem it addresses.

Related Resources

• What Is a MERIT Report? -- How pharmacist-authored summaries translate medication data for litigation
• Maximize Settlement with Medication Documentation -- Strategies for presenting pharmacy evidence effectively